GE will introduce Seno Advantage, a work-in-progress multimodality breast imaging offering, as well as technology gained from its October acquisition of Instrumentarium.
Seno Advantage will allow users to view ultrasound, mammography, MR, and PET/CT images to define and analyze non-specific breast tissue, tumor-like densities, density changes, and architectural distortions. FDA clearance is pending for the system, which the Waukesha, WI-based vendor hopes to make available early next year.
GE will also exhibit its FFDM system, Senographe 2000D, as well as Instrumentarium’s Diamond platform, which can be upgraded using digital stereo, digital spot, and 3-D capability with Instrumentarium’s tuned aperture computed tomography (TACT) technology.
Film-screen offerings include Senographe DMR+ and Performa, which features GE’s Easy Compression System and a compact design.
